Equels Thomas K bought AIM
September 14, 2026 · Form 4 insider transaction
Equels Thomas K bought 5,900 shares of AIM ImmunoTech Inc. at $0.22 per share, a transaction worth $1.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,900
Price
$0.22
Total value
$1.3K
InsiderEquels Thomas K
Role—
CompanyAIM ImmunoTech Inc. (AIM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 14, 2026
Filing dateSeptember 15, 2026
Shares owned after69,822
OwnershipDirect
10b5-1 planNo
AmendedNo